Articles On Uscom (ASX:UCM)

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

Local markets end slightly higher IT Sector slumps 1.2pc Small Caps led by AT1   The ASX 200 traded sideways again today, closing the day +0.1% higher as gains in Financials and Real Estate were offset by losses in Tech and Mining stocks....

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Benchmark ASX index closes ahead +0.19% Materials lead ASX sectors on Tuesday Small caps led by ERW, NMR   Local markets have struggled to hang onto early gains after a mixed run on Wall Street overnight. The benchmark ASX200 (XJO) index...

When the US sneezes economically, the rest of the world catches a cold. But when China sniffles, Australia is at risk of a full-blown bout of influenza. Last week the China gloom amped up a notch on reports of global banks cutting their gro...

ASX 200 climbs about 0.8% on a happier day than yesterday Unemployment jump to 3.7% in January eases concern over future rate rise severity NSW Government’s coal policy kicks miners square in the cokers   Good afternoon, and welcome to th...

Aussie markets end Friday on a -0.80% disappointment US signals new cannabis laws, good news for Aussie producers Zelensky the hot tip to win a rare mid-war Nobel Peace Prize   The ASX has dribbled  it’s way towards Friday’s -0.80% close,...

Uscom’s device is included in China’s emergency guidelines Poland provides grant for Immutep’s Phase 2 trial Medical device company Uscom (ASX:UCM) said that it has been included in the national emergency medicine guidelines for acute hea...

Uscom (UCM) receives Chinese regulatory National Medical Products Administration (NMPA) acceptance for four devices in its range of SpiroSonic spirometers This acceptance comes after more than two years of national testing by the regulator...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

In October, the Chinese government released its intellectual proprietary (IP) patents strategy paper, listing its main goals for the next five years. Part of that plan is to double the foreign “high value” patents from the current 40,000 to...

It’s only just ticked into November but it’s starting to feel a bit like Christmas – and the tail end of the pandemic, as nations re-open their doors and borders. But we will be dealing with the health consequences of Covid for years to com...

After yesterday’s drop, risk-on sentiment returned to Australia’s bourse today. The ASX 200 rose 0.9% to 7,327 points while the ASX Emerging Companies Index rose 0.3% to 2,167 points. Energy surprisingly dropped 1.91% after gaining substant...

The change from one financial year to the next saw several ASX company directors sell to pay forthcoming tax bills but also purchases as directors betted on the future. Code Company Director Change Date Volume $ What LGL Ly...

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

The ASX has begun the week in positive territory, albeit only slightly. The ASX 200 closed at 7,046 points, 0.22 per cent higher than Friday. The ASX Emerging Companies Index however retreated 0.35 per cent, closing at 2,114. The best secto...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

The Uscom Ltd (ASX: UCM) share price tumbled today after the company released its quarterly cash report, showing significant falls across every major category. The Uscom share price was down 6% at the close of trade today, at 15.5 cents pe...

Source: Have a nice day Photo, Shutterstock Summary Telix Pharmaceuticals has announced the launch of NOBLE Registry of its prostate cancer imaging agent. Global healthcare company Ramsay Health Care confirms the funding guarantee arr...

China’s economy is forecast to grow at a rate of 7 to 9 per cent in 2021, according to consensus estimates Chinese households and consumers have amassed a pool of wealth amid China’s economic rise and have spare cash to spend Several ASX c...

Medical device manufacturer Uscom Ltd (ASX: UCM) has today announced a significant increase in its sales and profits for the first 5 months of FY21. The Uscom share price lifted by 10% after the announcement, and is currently trading at 17...

Summary Uscom Limited informed the market today that Uscom China got listed as a National High Technology Enterprise. The National High Technology Entities are recognised as a national value. They are offered special assistance by seve...

A quick wrap of the ASX’s key winners and losers on Monday, July 13. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. Today 715 stocks rose, 639 decl...

In the past fortnight there were over 30 directors trades of $100,000 or more among ASX small cap directors. The list included multiple groups of directors. Five directors from water treatment stock Phoslock (ASX:PET) put in $1.3m between t...

Our summary of Uscom Ltd's recent announcement What's happened? Uscom Limited (ASX:UCM) today announced the signing of a development and supply agreement with A&D Limited of Japan. What are the key highlights? The agreement relates to...

The announcement lands just before markets open, ‘the TGA has approved our device’; the buy orders begin to pile up and the pre-open share price begins to surge. But while a nod from Australia’s drug and device regulator, the Therapeutic Go...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

As with the early medical cannabis plays, a cluster of ASX-listed stocks has wasted little time attaching itself to the ‘c’ word. We’re talking of course about the coronavirus COVID-19 but sadly not another ‘c’ word: cure. Or not yet. Accor...

The spread of coronavirus has infected global share markets with the contagion of fear. The S&P/ASX 200 Index (INDEXASX: XJO) has fallen more than 10% in the last fortnight as investors flee to safe havens. This week, the Reserve Bank...

In February, mounting coronavirus-led uncertainty finally culminated in a late-month share price bloodbath. After a 3 per cent gain in January, the S&P/ASX Emerging Companies Index – which gauges the health of the microcap sector – had...

Last week markets had their worst week since the global financial crisis (GFC) and the carnage, at least on the ASX, continued yesterday. A virus that began at a live meat market in Wuhan has now spread to over 80,000 people globally and th...

The Uscom Ltd (ASX: UCM) share price rocketed higher today following the announcement that the Chinese government has recommended one of its products for use in treating coronavirus. After surging as much as 38.7% in afternoon trade, Uscom...

Australian medical technology company Uscom (ASX: UCM) has posted a 35% drop in total revenue figures for the half-year ending December 2019, underpinned by a restructure to its China-based distribution model. In January, the company commis...

For weeks Zoono (ASX:ZNO) shares have surged as people demand its products wanting to protect themselves from the coronavirus, but maybe this wasn’t panic buying after all. This morning the hand sanitiser maker revealed the test results of...

As the coronavirus death toll rises to more than 1,000 and the World Health Organisation labels it a global health emergency, share markets are feeling the impact of the outbreak with Australian ASX-listed stocks not immune to the damage. C...

Today’s session proved much kinder to the Aussie market, delivering strong gains across the board as China’s factories came back online. While the dollar remained fairly stagnant, sectors, futures and indices did a 180, rallying to rever...

Australian shares rose to a two-week high as investors weighed positive overnight leads against the impact of bushfires and the coronavirus on company earnings. The ASX 200 advanced 51 points or 0.7 per cent to 7063, the index’s highest...

Two more coronavirus infections were released to the ASX in the last 24 hours, but while one was bad, it turns out the other wasn’t part of the epidemic at all. Uscom (ASX:UCM) says sales of its haemodynamic monitoring device in China, whic...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

The ongoing coronavirus outbreak in China is making itself felt in a commercial sense as medical technology company Uscom (ASX: UCM), a supplier of monitoring devices, announced a material increase in orders for its USCOM 1A device in China...

Over the past five weeks, Uscom (UCM) has received a material increase in demand for its USCOM 1A device in China The device is used to optimise the management of infectious diseases and accurately measures blood flow, cardiac output and...

A fresh decade-low for the dollar ended today’s session on a weak note, leaving Australian markets in the red. Despite attempts to climb against the greenback later in the day, the dollar was worth as little as 66.6 US cents this morning...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

With triple the number of sepsis cases in Australia, small cap biotech company Cynata Therapeutics (ASX:CYP) hopes to wage a new war on blood infections. Last Friday the world learned blood infections were on the rise, with researchers show...

Uscom (UCM) says the China National Medical Administration has certified extended sales of the USCOM 1A device China This certification is valid for five years and is the third consecutive approval for the device This approval allows cur...

Did you know that a hard-working stallion ejaculates 100 times more sperm than the average bloke? Given a virile, but weary, thoroughbred can service hundreds of mares in a breeding season, that’s just as well. But even the most virile of t...

Uscom Limited (ASX: UCM), an innovative medical technology company, has appointed four new US dealers to assist a new US sales and marketing strategy. The appointments of the new dealers assure that they will cover approximately 75% of the...

Ever since the advent of TV, worried parents have cautioned their kids that too much time in front of John Logie Baird’s infernal device will make them go blind – a warning routinely shrugged off by the juvenile couch potatoes. It seems tha...

We hate to sound like an old school report, but it’s been a year of steady and solid progress for the maker of non-invasive cardiac and pulmonary measuring devices, especially in its key target market of China. Achievements include record r...

Uscom Limited (ASX: UCM), an innovative medical technology company, announced the appointment of a new European Sales and marketing Manager, Dr Antonio Ferrario, who will co-ordinate the newly established Uscom sales and marketing hub in Bu...